Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Common Equity (2016 - 2025)

Historic Common Equity for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $2.0 billion.

  • Bio-Techne's Common Equity fell 324.77% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year decrease of 324.77%. This contributed to the annual value of $1.9 billion for FY2025, which is 725.24% down from last year.
  • Latest data reveals that Bio-Techne reported Common Equity of $2.0 billion as of Q4 2025, which was down 324.77% from $2.0 billion recorded in Q3 2025.
  • Bio-Techne's Common Equity's 5-year high stood at $2.1 billion during Q3 2024, with a 5-year trough of $1.5 billion in Q1 2021.
  • For the 5-year period, Bio-Techne's Common Equity averaged around $1.9 billion, with its median value being $1.9 billion (2023).
  • As far as peak fluctuations go, Bio-Techne's Common Equity surged by 1987.77% in 2021, and later plummeted by 808.15% in 2025.
  • Quarter analysis of 5 years shows Bio-Techne's Common Equity stood at $1.7 billion in 2021, then increased by 7.29% to $1.8 billion in 2022, then rose by 7.47% to $2.0 billion in 2023, then rose by 5.85% to $2.1 billion in 2024, then decreased by 3.25% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q4 2025, $2.0 billion for Q3 2025, and $1.9 billion during Q2 2025.